Impact of newborn screening for very-long-chain acyl-CoA dehydrogenase deficiency on genetic, enzymatic, and clinical outcomes.

Bleeker, JCKok, ILFerdinandusse, Svan der Pol, WLCuppen, IBosch, AMLangeveld, MDerks, TGJWilliams, Mde Vries, MMulder, MFSchielen, PCJIDekkers, Eetal2025-03-262025-03-2620193076155110.1002/jimd.12075https://rivm.openrepository.com/handle/10029/651793Impact of newborn screening for very-long-chain acyl-CoA dehydrogenase deficiency on genetic, enzymatic, and clinical outcomes.ArticleJ Inherit Metab Dis 2019; 42(3):414-232025-03-26